“Assessment tool for the quality
of hospital care for children with LLA”
DOTTORANDO: ENKELEIDA THARTORI TIRANA-ALBANIA
TUTORI: GIULIO ANDREA ZANAZZO TRIESTE-ITALY
GIORGIO TAMBURLINI TRIESTE-ITALY
June 27-28, 2012
TIRANA, ALBANIA
World Health Organization
Regional Office for Europe
Weltgesundheitsorganisat ion
Regionalbüro für Europa
Organisation Mondiale de la Santé
Bureau Régional de l'Europe
Assessment tool for the quality
of hospital care for children with LLA
®Acknowledgments
This tool is a revised and updated version of the assessment tool of a
paediatric hospital care in oncohematologic department, it is developed by
WHO CAH in 2001 and since then widely used globally. The first revision was
made by Dr. Giorgio Tamburlini (Institute for Maternal and Child Health “Burlo
Garofolo”, Trieste, Italy – WHO Collaborating Centre for Maternal and Child
Health) in a consultative process with the WHO Regional Office for Europe.
Table of contents
Introduction...1
General information...3
1. Information system and medical records...5
1.1 Availability of relevant information...5
1.2 Quality of medical records...5
2. Essential drugs, supplies and equipment...8
2.1 Drugs and chemotherapy drugs for LLA...8
2.2 Equipment and supplies...11
2.3 Standards for drugs, supplies and equipment...13
3. Laboratory support...15
4. Emergency care...18
4.1 Lay out, patient flow and staffing...18
4.2 Standarts of structure and staffing in the oncologic department……….21
5. Oncohematologic department facilities...25
6. Case management of LLA...29
6.1 Hemorrhage...29
6.2 Anemia...31
6.3 Fever Conditions...32
6.4 Pain in LLA children...36
6.5 Neurotoxicity...38
6.6 Metabolic complications and other conditions...41
7. Child friendly services...43
8. Monitoring and follow up...48
9. Guidelines and auditing...51
10. Access to hospital and feedback to primary health care...53
Annex 1...56
Mothers’ and other carers’ view on patients care...56
Annex 2...62
Health workers interview...62
Summary evaluation score...70
Debriefing and action plan...71
Main References...72
Introduction
This assessment tool helps to evaluate the quality of care (QoC) for children in oncohematologic department especially for those with LA (LLA and LAM), based on standards derived from the WHO Pocket Book of Hospital Care for Children, and, in a limited number of areas not included in the WHO Pocket Book, from international guidelines (see Main References) and protocols for onco- haematologic diseases from AIEOP-ITALY
It includes a series of forms to collect:
- general information on the physical structure of the paediatric
oncohematologic department, and, when appropriate, outpatient and day hospital;
- information on available equipment, drugs and supplies;
- information on (about?) management of common conditions which are usually dealt with the onco-haematologic paediatric department in specialized hospitals (tertiary care), including essential surgery when appropriate ex; CVC and sedation protocol
- views of staff and mothers/carers of sick children.
The information will be collected from four different sources of information:
hospital statistics, medical records, direct observation of cases, and interviews with staff and with mothers/caretakers. Through the combination of information from different sources the tool allows to build an overall diagnosis of the quality of care and to single out those areas that are most critical and in need of action to improve QoC.
A scoring system is proposed to identify the most critical areas: 3 = good quality of care according to international standards; 2 = need for some improvement to reach standard care (suboptimal care but no significant hazard to health); 1 = need for substantial improvement to reach standard care (suboptimal care with significant health hazards, e.g. omission of evidence based interventions and use of diagnostic and treatment which are not effective according to international standards and may also be potentially harmful to children); 0 = need for very substantial improvements (totally inadequate care and/or harmful practice with severe hazards to the health of these children).
Summary tables are included in each section to facilitate a quick synthesis of the findings, and a summary evaluation sheet is included to provide an overview of the situation, monitor department improvement over time and make inter-department comparisons when appropriate. All sections leave some space for comments by the assessors and for relevant additional information.
The assessment will be conducted by external assessors, usually two, at least one should have a significant experience in onco-haematological clinical paediatrics and be totally familiar with the reference protocols for LA.
Information(s) regarding sections 1 to 4 should be collected before the
assessment then analysed before the visit and whenever possibly checked
during the direct visit. It is suggested to spend as much time as possible on the
onco-haematological paediatric department to gain first hand information by direct observation, especially on the case management of LLA and LAM. Also, the assessors should check the existence and contents of clinical protocols, and whether the drugs and equipment listed are available.
We emphasise that the assessment is an exercise which is part of the initiative to help the only paediatric oncohaematological department in Albania to improve the quality of paediatric care, aimed at identifying areas of care that need improvement and a very clear definition of a program to intervene immediately in those areas that express really a huge lack.
The assessors should explain that they will also interview staff and mothers/carers about hospital routines for these children and practices and that they would like to observe care of as many patients as possible, already admitted as well as new arrivals.
The assessment will normally start with a tour of the onco-haematological department asking to be shown all areas that will be of relevance to paediatric care. In addition to the department the tour should include the following areas, when they exist: intensive care unit, pharmacy, laboratory, blood bank, radiology surgical department.
Observation over time is important and new arrivals and new admissions with LA to the hospital should be closely observed. It is an advantage if the hospital staff is asked to alert them when new patients arrive. The assessors should not interrupt, interfere or guide medical work in any way. It is important that they are allowed to move around freely and are free to interview parents and staff.
There is no time limit to the assessment and the more observations the better.
Allow for sufficient time to prepare the findings for presentation. Transfer all findings on the summary sheet of findings and action for discussion. A feedback meeting held at the end of the assessment is aimed at involving staff in discussing the findings as well as the suggested actions. Standards and assessment tools are essential but not per se sufficient to promote a sustained effort to departments quality improvement. A crucial component of quality development is represented by the commitment of hospital managers and health professionals. By its participatory nature and particularly through its final session, which is clearly inspired by a problem-solving approach, the process is aimed at building awareness about the existence of quality issues and the potential for improvement. The tool includes a suggested framework for final discussion and identifications of tasks and responsibilities of the various staff members and levels. The focus on case management of a child suffering of LA and organisational issues rather than on structure and staffing is crucial to promote the idea that substantial change is possible without major external input and resources.
Interviews with mothers about the quality of care provided to them and their
children clearly represent a novelty to most professionals. Incorporating the
views of mothers on several aspects of care is per se a way to promote child,
mother and family-friendly attitudes among staff, as well as awareness among
mothers and children about their own rights.
After assessing the planned sample of facilities the assessors prepare a report
summarizing findings and recommendations. The assessment process might be
included into a national quality improvement programme, or it might be done
by interested health authorities at UHC “Mother Teresa” and MOH involving the
onco-haematological paediatric department hospital walk-through observation . After
a predefined period of time, the assessment can be repeated to document
improvement.
General information
Source: walk-through observation, and interviews with chief /staff onco-haematological department
Instructions: Collect informations on numbers and time. Several questions have space for you to describe your answer in more detail .
Date of assessment: ... June 27-28
th2012
Name of interviewer(s).. Dott. Giulio Andrea Zanazzo
Paediatrician in oncohematologic service of IRCCS “Burlo Garofolo”-Trieste,Italy Name of the health facility University Hospital Center “Mother Teresa”-
Oncohematologic Pediatrician Service District... Tirane, Albania
Type of hospital (district, regional etc.)…National………:……….
Layout of health facility
Does the health facility have a separate outpatient
department? Y N,x
Comments ...
……...……
Is the paediatric outpatient separate from the
adult outpatient department? Y,x N
Comments ...
……...
Does the health facility have a separate
emergency department? Y,x N
Is it open 24 hours? Y,x N
If not, what hours is it open? …………
… Does the health facility have a department for
admitting children? Y,x N
If so, how many beds?
2 in Day Hospital…
16 in ward……
……
Does the health facility have a transplantation
unit for children ? Y N,x
If so, how many and describe?
Does the health facility have a separate room or areas for admitting the LA children in critical condition requiring special or intensive care admitted (isolation area or rooms)?
Y,x N
If so, how many beds?
… 7………
…
…………
… Describe: One room with a single bed with oxygen, central venous line pump, monitoring devices; 3 rooms with double bed in separate area
Does the health facility have a separate room to got different procedures (CVC, bone marrow aspiration.. etc)? (in general paediatric department, in paediatric surgical department, in oncohaematologic department, others)
Y,x N
Describe: Bone marrow aspiration, Lumbar punction.
Blood samplings, Sterile medications are performed in a dedicated room in Oncohematologic Department
Is a dedicated nurse available 24 hrs per day on
children's onco-haematologic department? Y,x N
Describe: There are 5 nurses present in ward during the morning and 2 others in the DH; afternoon time (13-19h) there are present 2 or 3 nurses in the ward;
during the night shift only 2 nurses
Is there a dedicated doctor available 24 hrs per day on children's onco-haematological department?
Describe: During the morning (08-16h) only 3 dedicated doctors, in the afternoon or in the night, there are no dedicated doctor, but each of them does the night shift 3 or 4 times in a month.
Sometimes they are on calling service.
Y N,x
Patient load
1. Information
system and
medical records
1. Source: routine statistics. This information should ideally be collected before the visit, and be available for reference during the visit. If it has not been collected before, collect the information early during the visit from the statistical office, chief nursing officer of the department, or hospital administration.
1.1 Availability of relevant information
Criteria 0 1 2 3 Comments
Availability of relevant statistics and information Existence and quality of
paper based information system on patient flow (admissions, outpatients, etc.)
X
Existence of computer based medical record system
X
1.2 Quality of medical records
Criteria 0 1 2 3 Comments
Medical records
Medical records are clear and legible X
0-14 years old LLA LAM
2005 23 8
2006 23 1
2007 19 3
2008 17 1
2009 33 5
2010 29 2
TOTALLY 144 20
AVARAGE 24 3.3
Medical records are dated X All admission and discharge of LA
children are clearly written in the notes
X
All drugs and treatments are clearly identifiable
X
Written informations about previous
admissions are available to staff X
Other relevant issues concerning information system (specify and comment) A total lack of nurses records
Summary:
Availability of relevant statistics and information
Criteria 0 1 2 3 Comments
Availability and quality of relevant
statistics X
Quality of medical records X
Main Strength Easy using and well completed of medical record
Main Weaknesses Totally lack of nurses record. There are lack of signature from the nurse who confirms the therapy administration.
Additional Comments Overall score for section
Summary score –
Availability of relevant statistics and quality of medical records Good To be improved
(to be circled) 3 2 1 0
2. Essential drugs, supplies and equipment
Source: This information should ideally be collected before the visit, and be available for reference during the visit. If it has not been collected before, collect the information early during the visit from the department and the pharmacist. If appropriate, add drugs .
2.1 Drugs
Please indicate the drugs available. Check for the actual availability of drugs and enquire with staff whether drugs are regularly available.(especially cytostatic drugs).
If some drugs are only available for sale (or only in certain conditions), or are expired make a note.
I.V. Solutions Always Common Rarely Never
Glucose 30-50% IV
Glucose 10 % IV
Glucose 5 % IV
Normal saline IV
Ringer’s lactate IV
Other solutions: KCl -10ml
vial, NaCl 10ml vial,
Ca Gluconat, Esafosfina
10g-100ml , etc… …
Emergency drugs Adrenalin or epinephrine
Atropina
Digoxin
Corticosteroids
Dopamine, Dobutamine,
Nifedipine
Furosemide
Diazepam
Phenobarbital
Antibiotics/antimycotics/antihelmintic drugs (Supportiv Therapy)
Ampicillin
Amoxycillin
Amoxy-clavulanic
1,2,3 Generation
cephalosporines
Other 4
rdgeneration Cephalosporins (Cefepime, Cefpirome etc…………..)
Antistaphylococcal-
(glicopeptids)
Vancomycina
Teicoplanina (targozid)
Fluorochinolon:
Ciprofloxacin,
Levofloxacin
Aminoglycosid.
Gentamycin, amicacin
Macrolides:Eritromycin,
clarithromycin
Azitromycin
Cotrimoxazole (bactrim)
Antiviral;Acyclovir,
Ganciclovir
Metronidazole(flagyl)
Antifungals; Fluconazole/
Ketoconazole, voriconazol
Amphotericin B
Cytotoxic(antineoplastic) drugs= Chemotherapy drugs in LLA
Vincristine
Daunorubicine adriamycin
Steroids: Prednison,
dexametason
Methotrexate os
Methotrexate ev
6 Thioguanina
6 mercaptopurin
Asparaginase :(L-ASP or
P-ASP)
ARA-C
Ciclophosphamid
Folinic Acid: Citrovorum
factor
Supportive drug therapy
Antiemitics: ondansetron,
granisetron(kytril)
Metoclopramide,
Proclorperazina etc
AntiH2, Ranitidine,
Cimetidine etc..
Proton pump inhibitor:
Omeprasol, Lansoprasol
Filgrastim (Neupogen,
Peg-Filgrastim)
Sedation drugs
(propofol…, midazolam) Allopurinol
Rasburicase
Blood support therapy Hemotransfusion
Fresh frozen plasma FFP
Platelets mass or by apheresys
2.2 Equipment and supplies
Source: This information should ideally be collected before the visit, and be available for reference during the visit. If it has not been collected before, collect the information early during the visit from the oncohaematologic department and the store.
Is the following equipment available in on the department, or in the pharmacy or store? Check the information obtained in advance during the visit to the department and to the pharmacy. Ask the person in charge of the area/department for the items to be shown to you, and check that they are kept safe and in good working order. Check that the size are adequate for use in infants and children.
Department Pharmacy / store
hospital
Comments
Resuscitation table/ couch Resuscitation bag
Torch
Otoscope
Scales for children
Measuring board to measure length and height (lying/ standing according to age)
Stethoscopes
Thermometers
Oxygen Source
oxygen cylinder central
supply
Flow-meters for oxygen Equipment for the
administration of oxygen Indicate
which equipment you use:
(please tick)
nasal prongs
Masks
Blood pressure cufs
Oxygen saturimeter
Masks
infant size child size
adult size
IV-giving sets with chambers for paediatric use?
Lack of CVC
Biological Safety
Cabinets(cover drugs) for hazardous drugs.
Butterflies and/or cannulae
of paediatric size?
CVC equipment?
Totally implanted tunnelized
Indicate type of CVC set
Lumbar needles
Bone marrow needles
Needles for bone marrow biopsy
not at all evident
Colors for smears
Glass for blood smears
Functional X-ray
equipment
Ultrasound equipment,
CT-scan
RMN
Echography
ECG
………..
Flexible bronchoscopy and
BAL Not at all evident
EEG
Optic Microscop
Cytocentrifugal equipment
2.3 Standards for drugs, supplies and equipment Standards
- Availability of drugs
- Availability of supplies and equipment
Use the information collected in the previous sections to score the various items in this section.
Criteria 0 1 2 3 Comments
Availability of drugs
the essential drugs in list for LLA exists
Drugs on the list are adequate for the management of LLA disease.
x x
Essential drugs are available on the department and in the emergency area and immediately accessible
x
Drugs are never expired x
Oldest drugs are used first x
Availability of supplies and equipment Essential equipment is immediately available for use.
x Essential equipment is safe and in
working order
Essential supplies are available immediately, and are adequate for use in children with LLA
x
Summary:
Essential drugs, supplies and equipment
Criteria 0 1 2 3 Comments
Essential drugs are available and are
not expired X
Essential equipment is available and in
good working condition x
Adequate equipment is available on
the department. x
There is an adequate range of I.V.-
fluids and CVC procedures x
Adequate X-ray and Echo equipment
are available and in good condition x
Main Strengths
_________________________________________________________________________
Main Weaknesses:
Chronic lack of antiblastic drugs, a relative poor existence of supportive drugs.
CVC totally inexistence does not allow to apply a median or high intensity of chemiotherapy like the updating protocols suggest.
Additional Comments:
Knowing this context, the family of an ill child must buy by themselves the most of drugs outside of hospital, in a private store or pharmacy.
Overall score for section
Summary score – Essential drugs, supplies and equipment Good To be improved
(to be circled) 3 2 1 0
3. Laboratory support
Source: This information should ideally be collected before the visit and be available for reference during the visit. If it has not been collected before, collect the information early during the visit from the laboratory and chief laboratory technician .
Check whether the essential laboratory investigations are promptly available (e.g. Hb, total blood count, ). If available sign time to get results
Laboratory Test available Not available Time to
get results Comments
Total blood count with formula Citomorphology of peripheric
blood
Central Laboratory
Reticolocyte
Blood grouping and crossmatch
Bilirubin total and direct
Alt, Ast, gamma-GT
PCR, VES, Procalcitonina No Procalcitonin
Ferritin blood test
LDH, ALP, Proteinemia
Blood glucose
Serum creatinine, azotemia,
Acid uric test
Pancreatic amylasemia
Cholesterol, Triglicerid
Electrolytes:Na, K, Cl, P, Ca, Mg
INR, APTT
Fibrinogeno, Antitrombine III
D-dimero
Methotrexatemia
CSF citomorphology Central Laboratory
EmoGasAnalysis
Urine microscopy
Stool culture
Blood samples, culture of central
venous line
Urine culture
Serologie for EBV, Hepatitis B,
CMV, Parvovirus EBV, CMV, Parvovirus only in
private way, not in the hospital
Bone Marrow citomorphology
Citochimical test of bone marrow
Immunophenotip of blastic cells 4 hours
Genetic Analyses, genotips of
bone marrow
Translocation t (9;22),
philadelphia chromosome, Ph+
Summary:
Laboratory support
Criteria 0 1 2 3 Comments
Essential laboratory tests are always available and their results are delivered timely to the Oncohematological department
x Time to get the results is the biggest problem. This is due to:
1. It is not an adequate or perfect system of administration and organisation of hospital laboratory service.
2. Many tests are performed outside of hospital service
Financial barriers do not deprive patients of the use of essential laboratory test to put the dg of LLA (either they are free of charge, or there are exemption schemes in place for) uninsured children)
x
Main Strengths Main Weaknesses:
1. It is a high impossibility to treat patient with high doses of Methotrexate in such conditions like; HR LLA, OSTEOSARCOMA…etc
2. A high impossibility to isolate the kind of a germ in an infectious condition in operative time.
3. A high impossibility to make the diagnosis by identifying the basic risk factors such as: exp
PH+LLA… etc
Additional Comments:
Overall score for section
Summary score – Laboratory support Good To be improved
(to be circled) 3 2 1 0
4. Emergency care
4.1 Lay out, patient flow and staffing
Source: Visit to the department and interviews with staff dealing with LLA children. Interview staff about when emergencies would present, who would see them; how senior staff are called, and where and how severe conditions are handled.
The LLA patients with an emergency medical or surgical condition do they received the care in the department?
…………yes……….………
Describe patient flow of a typical emergency of LLA (patients with LLA presenting as an emergency to hospital)
……….………
How are handled the outpatient (day-hospital) in your department (i.e. patients presenting normally to the day-hospital, but severely ill)?
They have the appointment describing by the doctor
……….………
Describe patient flow for a month in the oncohematologic department.
It depends from the patient flow, the season, but a full service is of 18-een patient Is there any system in place to prioritize severely LLA children in critical
condition? Y No, x
If so, describe: .………
Is there single rooms or management area equipped to take care of these
children? A sedation room? N
If so, describe: There is only a sedation room where the main procedures are done, named the Nursing Room
Is there a separate area with filtrate air for these children? Y No,
If so, describe: .……….
Does you have a separate room or area in the department for preparing the
drugs that are cytotoxic(for antineoplastic drugs)? Y N
If so, describe: .The antineoblastic drugs are prepared in the nursing room not in a dedicated
room .
Do patients come with referral notes when they have been referred from first or second level units?
never sometimes always
Comments: .……….……
Are there any job aids (wall charts, chart booklets) displayed for the
management of the children with LLA or oncological paediatric care? Y N
If so, describe about what, and comment on adequacy:………
Distance from the room where is settled the child to the other area;
Is there A single room with its own toilette? ....yes...
In another medical area, distance ...
Distance from principal gate of hospital to the oncohematologic department;:
The department has its own gate directly? ...yes...
This concerns staff who are immediately available to deal with LLA children and their level of training
Type of staff
during working
hours
Present/
not present If present, number
night working
hours
Present/ not present If present,
number
Trained in assessment/
detection of care in a LLA child
Yes/No
Trained in management
of oncological
conditions
Yes/No
Remarks
Gateman 2 0
Admin.ve
staff 0
Nurse (generic)
16 Nurse/day (paediatric)
5 2-3
Auxiliary 3 0
Medical officer (generic)
0 0
Medical
officer 3 1 1/3 yes
(paed
specialist)
4.2 Standards of structure and staffing in Oncohaematological Department Standards
- Layout and structure available for the treatment of LLA - Drug, supplies and equipment (chemotherapeutic drugs) - Staffing
- Case management - Transplantation unit - Palliative care
Criteria 0 1 2 3 Comments
Layout and structure
Children are assessed for severity/ priority signs immediately on arrival
X
Patients do not have to wait for registration, payment, their turn etc.
before a first assessment is done and action taken
X
A wall chart or job aid for identifying children by severity of condition is located in the emergency admissions area
X
Drug, supplies and equipment
1(see below) Essential drugs for emergency conditions and chemotherapeutic treatment of LLA are always available and free of charge to the family
X
Essential lab tests ( Hb or Hct, biochemical test, BM morphology) are available and results are obtained timely
X
Essential equipment (needles and syringes, lumbar needle, needle for bone marrow aspiration, nasogastric tubes, oxygen equipment, self inflating resuscitation bags with masks of different sizes,) is available
X
Staffing
A qualified staff member is designated to carry out the LLA child
X
1
Drugs, supplies and equipment
Please refer to the tables above. Please note when judging the adequacy of supplies that some drugs (e.g. oxygen,
anticonvulsants) need to be immediately available, whereas for others (e.g. antibiotics) it suffices if access is assured.
A health professional is available without delay to manage the children determined to have an LA
X
Case management
2(see below)
Staff doing oncologic conditions is trained in the guidelines and protocols of LLA and can implement them appropriately during peak hours
X
Staff is skilled in the management of common LA conditions and starts treatment without delay: management of hemorrage, strong pain, severe shock and severe chemioterapeutic complications etc
X
Transplantation Unit
The hospital offer the transplantation of human cells for LLA children who have the criteria for it
X
Palliative care
There is this approach that improves the quality of life of these children and their families
X
Assessment and treatment of pain and other problems, physical, psychosocial and spiritual
X
Summary:
Structure, equipment, drugs and case management of LLA in the department
Criteria 0 1 2 3 Comments
Layout and physical structure of the
oncohematologic department X
Adequate staffing dedicated to LLA X Availability of essential drugs for LLA X
Availability of essential laboratory
support for LLA X
Possibility of cells transplantation X
2